Abstract
Background: Enhanced visual food cue reactivity has been associated with overeating and weight gain. Due to the increasing prevalence of high-fat food images that we are constantly exposed to in both the real and the virtual world, methods that are able to reduce the reactivity to these types of cues are urgently needed. This eye-tracking study investigated whether food cue reactivity, especially toward high-caloric food, can be reduced with a placebo intervention. Method: Fifty-two women [mean body mass index (BMI) = 23.5] were presented with pictures depicting combinations of food (high-caloric, low-caloric) and non-food items, which were shown once with and once without a placebo in a repeated-measures design. The placebo was a pill introduced as a medication targeting peptide YY that is able to reduce appetite specifically for high-caloric food. Gaze data (dwell time, fixations) and self-reported appetite were assessed during the two eye-tracking sessions (with/without placebo). Results: The placebo reduced general appetite as well as specific appetite for the depicted food items. Additionally, the placebo decreased the percentage of fixations and dwell time on the food images. The placebo was not able to specifically change visual food cue reactivity to high-caloric stimuli but reduced responses to both high-caloric and low-caloric food. Reported appetite reduction and weight concerns were positively associated with the placebo-related decrease in visual attention for food. Conclusions: The placebo was able to reduce visual food cue reactivity. This finding demonstrates that placebos are able to alter early visual–attentional processes.
Highlights
Food is a primary reinforcer that attracts automatic attention
A regression approach was used in order to analyze whether reported concerns about weight and eating as well as body mass index (BMI) would be associated with placebo-related effects on eye movements and appetite. This was done in order to investigate if overweight women who would like to lose weight might profit from this type of placebo intervention
In order to investigate placebo effects on general appetite, an analysis of variance (ANOVA) for repeated measures was computed with the within-subject factors Treatment (Placebo, No placebo treatment (Placebo)) and Time of Measurement
Summary
Enhanced visual food cue reactivity has been associated with overeating and weight gain. Due to the increasing prevalence of high-fat food images that we are constantly exposed to in both the real and the virtual world, methods that are able to reduce the reactivity to these types of cues are urgently needed. This eye-tracking study investigated whether food cue reactivity, especially toward high-caloric food, can be reduced with a placebo intervention. The placebo was a pill introduced as a medication targeting peptide YY that is able to reduce appetite for high-caloric food. Gaze data (dwell time, fixations) and self-reported appetite were assessed during the two eye-tracking sessions (with/without placebo)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.